Corporate News     26-Feb-25
Gland Pharma allots 4,700 equity shares under ESOP
Gland Pharma has allotted 4,700 equity shares under ESOP on 26 February 2025. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,756,423/- comprising 164,756,423 equity shares of face value Re.1/- each.
Previous News
  Gland Pharma Ltd soars 1.09%, Gains for third straight session
 ( Hot Pursuit - 12-Dec-23   13:05 )
  Gland Pharma gets EIR from USFDA for Dundigal facility
 ( Hot Pursuit - 16-Jan-25   13:00 )
  Gland Pharma appoints Srinivas Sadu as executive chairman & CEO
 ( Hot Pursuit - 08-Jun-24   13:23 )
  Gland Pharma
 ( Results - Analysis 07-Aug-24   09:34 )
  Gland Pharma consolidated net profit rises 144.56% in the March 2024 quarter
 ( Results - Announcements 23-May-24   07:36 )
  Gland Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 19-Sep-24   13:35 )
  Gland Pharma Ltd up for third straight session
 ( Hot Pursuit - 07-Mar-25   13:05 )
  Gland Pharma Ltd leads losers in 'A' group
 ( Hot Pursuit - 21-Jul-22   15:00 )
  Gland Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 20-Feb-23   09:32 )
  Volumes soar at Gland Pharma Ltd counter
 ( Hot Pursuit - 09-Apr-24   14:30 )
  Gland Pharma gets EIR from USFDA for Pashamylaram facility
 ( Hot Pursuit - 18-Jan-25   10:50 )
Other Stories
  Tata Chemicals receives affirmation in LT corporate family rating
  17-Apr-25   20:24
  Board of NTPC appoints director
  17-Apr-25   20:17
  SBI Cards announces appointment of nominee director
  17-Apr-25   20:15
  Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
  17-Apr-25   20:08
  Suzlon Energy allots 99,000 equity shares under ESOP
  17-Apr-25   20:05
  UTIAMC allots 10,654 equity shares under ESOS
  17-Apr-25   20:03
  Indian Oil Corporation to announce Quarterly Result
  17-Apr-25   17:17
  Infosys to convene AGM
  17-Apr-25   17:17
  Board of Infosys recommends final dividend
  17-Apr-25   17:12
  Board of NHPC to consider bond issuance up to Rs 2,000 cr
  17-Apr-25   16:50
Back Top